Lipids and Lipoproteins Flashcards
what are the features of Isoprenoids
-three acetyl CoA (a 2 compound acetyl CoA) to generate a IPP (isopentenyl pyrophosphate) a 5 C compound
IPP which serves as a building block for synthesis of all isoprenoids
these include steroids, lipid soluble vitamins, ubiquinone, and prenyl groups to anchor proteins to Plasma membranes
what are the sources of Acetyl CoA
generated in Mitochondria via
- pyruvate
- fatty acids
- Amino acids
then transported to cytoplasm via the citrate shuttle
what is the back bone of steroids
six units of IPP to make a tetracyclic sterane ring
serves as back bone of steroids
what is the structure of cholesterole
Allicyclic compound made of 4 fused rings
has 27 carbons
and one hydroxyl group at C 3
characteristics of cholesterol
found in Plasma membranes and things like bile acids and bile salts, vitamin D, steroid hormones (progesterone, aldosterone, cortisol, testosterone, estradiol)
cells cant degrade steroid nucleus of cholesterol
must be used biochemically or excreted by liver, Excess cholesterol can lead to athersclerosis
how much cholesterol is produced
0.75 - 1 gram made in the liver but also in small intestine, adrenal cortex, ovaries, testes, and skin’
biosynthesis inversely proportional to dietary intake
what does cholesterol need to be made
18 acetyl CoA 18 ATP 16 NADPH and will finish with 27 carbons
Phase 1 of making cholesterol
Acetyl CoA
Acetoacetyl CoA
HMG CoA
-enzyme used to make this is HMG CoA synthetase
Mevalonate
-enzyme used to make this HMG CoA reductase (rate limiting step)
then to IPP
Phase II of making cholesterol
IPP to make Squalene
lanosterol
cholesterol
what inhibits HMG CoA reductase and some side effects
Statins used to lower amount of cholesterol
-lovastatin, simvastatin, pravastatin, atorvastatin
can lower up to 60 percent of cholesterol
very strong competitive inhibitor
- Ki is 5-45 nM compared to natural 4 uM
- binds in cytosol of the catalytic domain
also has a hypocholesterolemic action by increasing SREBP maturation to increase transcription of LDL receptor and help clear cholesterol in blood via LDL mediated endocytosis
Myotoxic side effects: duue to inhibit production of IPP which is important in the production of ubiquinone (CoQ) impairing mitochondrial function and then degeneration of myocytes
-can supplement this though
what is the fate of cholesterol
cholesterol is esterfied to cholesterol esters by the enzyme Acyl CoA cholesterol acyltransferase (ACAT)
then is packaged into VLDL and released into the blood to go to various organs to be used
what is the regulation on Cholesterol synthesis
regulated at rate limiting step
- Direct inhibition by free fatty acids, bile acids, and statins
- Covalent modifications: enzyme is inactive when phosphorylated and activated when dephosphorylated
in low energy, high AMP, activate AMPK will phosphorylate HMG CoA reductase
- insulin will activate HMG CoA reductase
- glucagon will deactivate HMG CoA reductase
also is controlled by transcription, translational , and post translational
Mechanism of Transcriptional control
HMG CoA reductase has a sterol regatory element in its promotor region
- SREBP (binding proteins) in inactive form
- activates SCAP (SREBP clevage activating protein
- in presence of cholesterol, SREB-SCAB complex will be retained in ER due to binding of INSIG
-if low cholesterol, SREBP-SCAP complex will go to golgi and undergo proteolysis and mature to have SREBP translocate to nucleus to bind SBE to increase transcription of HMG CoA reductase
function, and structure of Lipoproteins
serve as vehicles for transport of cholesterol, cholesterol esters, TAGS, and fat soluble vitamins
outer layer: monolayer of phospholipids, free cholesterol, and apolipoproteins
inner core: packed with TAGS, cholesterol, cholesterol esters
- lipoprotiens help transfer and deliver TAG
- lipoproteins help with Cholesterol homeostasis
- apolipoproteins Targeting signals/ligands
- apolipoproteins activate various enzymes
what are the 5 different lipoproteins
Chylomicrons
Very low density lipoproteins (VLDL)
Intermediate density lipoproteins (IDL)
LOw density lipoproteins (LDL) (bad cholesterol)
High density lipoproteins (HDL (good cholesterol)
this is also same goes for size in that order
what 5 lipoproteins contains the most percentage TAGS?
cholesterol?
Proteins?
Chylomicrons have most TAGs but least protein
LDL: highest percentage of cholesterol relatve to size
HLDL: least TAGS but highest protein make up
structures found on a chylomicron and its properties
ApoB-48 : facilitates transport
ApoC-II : activates capillary lipoprotein lipase
ApoE: facilitates uptake into liver
Exogenous and formed from dietary fats
- largest
- least dense
- High TAG
structures found on VLDL and properties
ApoB-100: uptake into cells
ApoC II: activates capillary lipoprotein lipase
ApoE: facilitates uptake into liver
- made in liver
- packaged with TAGs and cholesterol
structures found on IDL
ApoB-100: uptake into cells
ApoE: facillitates uptake into liver
Structures found on LDL and properties
ApoB-100: uptake into cells
bad cholesterol
no TAGs
lots of cholesterol
structures found on HDL and properties
ApoA-1: activates enzyme that esterfies cholesterol
ApoC-II: activates capillary lipoprotein lipase
ApoE: promotes uptake into hepatocytes
good cholesterol
- smallest
- most dense
- high protein and phospholipid content
Chylomicron processing
1) nascent chylomicrons are assembled with dietary lipids in the small intestine and transported through the lymp back to the blood stream
2) additional apoproteins are added to create a mature chylomicron (apoC-II and ApoE are supplied by HDL)
3) Capillary lipoprotein lipase hydrolyzes TAGs into glycerol and free fatty acids then ApoC-II is released back to HDL
4) remnants areendocytosed by the liver via binding to ApoE to its receptor
Type I and III proteinemia
these affect either the ApoC-1, ApoE or the capillary lipoprotein lipase
VLDL, IDL and LDL processing
1) VLDL are assembled in the liver and released into the bloodstream
2) Capillary lipoprotein lipase hydrolyzes TAGs into glycerol and free fatty acids then ApoC-II is released and now just IDL remains
3) Cholesterol in IDL is delivered back to the liver via binding ApoE to IDL receptors in liver cells
half of IDL lose more TAG via action of the hepatic lipoprotein lipase and then will lose ApoE to become LDL
4) LDL deliver their cholesterol load to the liver and peripheral tissue of ApoB-100 to LDL receptors on target cell